Billionaire Profile
Christian Boehringer
Global Rank
#602

Image: Unknown authorUnknown author | Public domain | via Wikimedia Commons

Christian Boehringer

CEO, Pharmaceuticals
GERMANY
Real-Time Net Worth
$6.636B
Estimated based on Pharmaceuticals stock value as of April 20, 2026
0% (24h)
Age
60
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
GERMANY

Biography

Christian Boehringer, at 60 years old, is a key figure in the pharmaceutical industry, deriving his wealth from Boehringer Ingelheim, the world's largest privately-owned pharmaceutical company. Boehringer's career is rooted in the legacy of his great-grandfather, Albert Boehringer, who founded the company in 1885. As Chairman of the Shareholders' Committee from 2007 to 2025, Christian Boehringer played a pivotal role in upholding the company's founding principles and steering its strategic direction. With a net worth of $6.6 billion as of March 2026, Christian Boehringer is a testament to the enduring success of Boehringer Ingelheim's commitment to pharmaceutical innovation and long-term vision.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life

Christian Boehringer's connection to the pharmaceutical world is deeply rooted in family history. His great-grandfather, Albert Boehringer, founded Boehringer Ingelheim in 1885 in Ingelheim am Rhein, Germany. The company initially produced tartaric acid but quickly transitioned to producing pharmaceuticals.

Rise to Success

Christian Boehringer's career at Boehringer Ingelheim evolved over time. He served as Chairman of the Shareholders' Committee from 2007 to 2025. During his tenure, Boehringer Ingelheim grew into a global enterprise with over 54,000 employees and a presence in 130 markets.

Key Business Strategies

Boehringer Ingelheim's success is attributed to its focus on long-term goals, research, and development. The company reinvests a substantial portion of its revenue, approximately 20-25%, into R&D annually. This commitment has resulted in a pipeline of innovative treatments for various diseases, including respiratory diseases, cardiovascular and metabolic diseases, oncology, and diseases of the central nervous system. Boehringer Ingelheim has also expanded its presence in Animal Health.

Philanthropy

Information regarding Christian Boehringer's specific philanthropic initiatives and amounts could not be found, as Boehringer Ingelheim is a private company and details are not always made public.

Career Milestones

2000

International Management

Worked in international management at Henkel KGaA in Düsseldorf for three years.

2007-2025

Chairman of the Shareholders' Committee

Served as Chairman of the Shareholders' Committee of Boehringer Ingelheim, representing the interests of the owning families.